Literature DB >> 16105165

Hyperkalaemia with cyclooxygenase-2 inhibition and hypoaldosteronism.

Q Lam, H-G Schneider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16105165     DOI： 10.1111/j.1445-5994.2005.00900.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  3 in total

1.  Risk of hyperkalemia associated with selective COX-2 inhibitors.

Authors:  Hisham Aljadhey; Wanzhu Tu; Richard A Hansen; Susan Blalock; D Craig Brater; Michael D Murray
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-11       Impact factor: 2.890

2.  Etoricoxib-induced life-threatening hyperkalemia and acute kidney dysfunction against the background of telmisartan and a low sodium diet.

Authors:  Swagata Tripathy; Suresh Chandra Dash
Journal:  Int J Emerg Med       Date:  2010-08-20

3.  The association between nonsteroidal anti-inflammatory drugs and potassium concentrations: A pharmacoepidemiological study in Saudi Arabia.

Authors:  Hisham Aljadhey
Journal:  Saudi Pharm J       Date:  2011-08-23       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.